Afficher la notice abrégée

Substance use and universal access to HIV testing and treatment in sub-Saharan Africa: implications and research priorities

dc.rights.licenseopenen_US
dc.contributor.authorLANCASTER, K.E.
dc.contributor.authorHETRICK, A.
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorJAQUET, Antoine
dc.contributor.authorADEDIMEJI, A.
dc.contributor.authorATWOLI, L
dc.contributor.authorCOLBY, D.J.
dc.contributor.authorMAYOR, A.M.
dc.contributor.authorPARCESEPE, A.
dc.contributor.authorSYVERTSEN, J
dc.date.accessioned2020-11-23T15:35:34Z
dc.date.available2020-11-23T15:35:34Z
dc.date.issued2018
dc.identifier.issn2055-6659 (Electronic) 2055-6640 (Linking)en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/15586
dc.description.abstractEnAs universal testing and treatment for HIV, or ‘treat all’, expands across sub-Saharan Africa (SSA), substance use will likely have a negative impact on the success of scale-up efforts for antiretroviral treatment (ART). Overwhelming evidence highlights the negative impact of substance use on HIV care and treatment outcomes. Yet, as many countries in SSA expand ART, evidence of the extent of substance use, and its impact in the region, is more limited. Stigma, and the psychoactive effects of substance use, are barriers to seeking HIV treatment and adhering to ART regimens for persons with heavy alcohol use or substance use. As a result, we identified several implementation and operations research priorities and metrics for monitoring the impact of substance use and Treat All. Identifying barriers and facilitators to the integration of the prevention and treatment of substance use with HIV care, and assessing effects on HIV outcomes, through longitudinal studies are priorities that will determine the impacts of substance use on ‘treat all’ in SSA. Future research must use existing infrastructure, including large networks of HIV clinics, to enhance our understanding of the implementation and service delivery of substance use screening, referral and treatment. These networks will also inform robust and standardised substance use estimates and interventions within the ‘treat all’ era in SSA.
dc.language.isoENen_US
dc.subject.enIDLIC
dc.title.enSubstance use and universal access to HIV testing and treatment in sub-Saharan Africa: implications and research priorities
dc.title.alternativeJ Virus Eraden_US
dc.typeArticle de revueen_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
bordeaux.journalJournal of Virus Eradicationen_US
bordeaux.page26-32en_US
bordeaux.volume4en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - U1219en_US
bordeaux.issueSuppl 2en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.teamIDLICen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-03193068
hal.version1
hal.date.transferred2021-04-08T13:26:30Z
hal.exporttrue
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Journal%20of%20Virus%20Eradication&rft.date=2018&rft.volume=4&rft.issue=Suppl%202&rft.spage=26-32&rft.epage=26-32&rft.eissn=2055-6659%20(Electronic)%202055-6640%20(Linking)&rft.issn=2055-6659%20(Electronic)%202055-6640%20(Linking)&rft.au=LANCASTER,%20K.E.&HETRICK,%20A.&JAQUET,%20Antoine&ADEDIMEJI,%20A.&ATWOLI,%20L&rft.genre=article


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée